Company chart and information is provided by TradingView based on 15-minute-delayed data.
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
| Website: | www.pharvaris.com |
| Email: | info@pharvaris.com |
| Main Phone: | +31 712036410 |
| Address: | J.H. Oortweg 21 |
| City / Town: | Leiden |
| Country: | NL |
| Postal Code: | 2333 CH |
| Exchange: | NGS |
| CEO: | Berndt Modig |
| Employees: | 14 |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
